Evidence map›Paper›PMID 42662081›Full record

ArticleESMO gastrointestinal oncology2026

Adjuvant chemotherapy with or without targeted therapy for patients with resectable synchronous colon cancer and liver or lung-confined metastases: a nationwide Taiwanese database study.

P-Y Chen, Y-H Liang, B-R Lin, C-H Hsu, Y-Y Shao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ESMO gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

P-Y ChenDepartment of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
Y-H LiangDepartment of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
B-R LinDepartment of Surgical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
C-H HsuDepartment of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
Y-Y ShaoDepartment of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The efficacy of targeted therapies in patients with resectable synchronous colon cancer and liver- or lung-confined metastasis (SCCLM) following curative surgery remains unclear. Patients and methods: A population-based cohort of patients with Results: A total of 804 patients were included in the analysis. Conclusions: The addition of targeted therapies to adjuvant chemotherapy following curative surgery in patients with SCCLM did not improve OS or TTF. This finding suggests that adjuvant chemotherapy alone may be the preferred therapeutic approach in this patient population.

Indexed as

adjuvant chemotherapyColon cancerresectable synchronous colon cancer and liver- or lung-confined metastasis (SCCLM)targeted therapy

Identifiers

PMID42662081
PMCPMC13519075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.